Side Effects to Be Aware of When Beginning Treatment The most common side effects during retatrutide initiation are gastrointestinal, particularly nausea, and are generally dose-dependent and transient
Rybelsus and the oral Wegovy pill are peptides essentially the same injectable molecule wrapped with absorption enhancers
Use of GLP-1 drugs is highest among adults who report being diagnosed with conditions these drugs are prescribed to treat, including those who have ever been told by a doctor that they have diabetes (57% ever used, including 45% currently using), heart disease (40% ever, 29% currently), and those that have been told by a doctor that they are overweight or obese in the past five years (34% ever, 23% currently)
Most of these side effects improve after the first few times you take the medication
Short-Term Use for Specific Goals Some patients may use GLP-1 medications for a shorter period to achieve specific weight loss goals, such as losing a certain amount of weight for an event or to improve a health condition (for example, reducing blood pressure)
decreasing glucagon production reduces the amount of endogenous glucose produced by the liver (see Figure)